Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )

Beyond second-line therapy: New hope for mCRC patients in Egypt

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Beyond second-line therapy: New hope for mCRC patients in Egypt ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Multi-target kinase inhibitors: From data to practice

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Multi-target kinase inhibitors: From data to practice ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Pharmacology update from ONS 2019 ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Anti-cancer compound for brain cancer found in daffodils

Dr Lorenzo Caggiano - University of Bath, Bath, UK

Anti-cancer compound for brain cancer found in daffodils ( Dr Lorenzo Caggiano - University of Bath, Bath, UK )

ALK-positive NSCLC: Treatments and latest developments

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong

ALK-positive NSCLC: Treatments and latest developments ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )

ALK-positive NSCLC: Current landscape

Dr Antonio Passaro and Prof Rafal Dziadziuszko

ALK-positive NSCLC: Current landscape ( Dr Antonio Passaro and Prof Rafal Dziadziuszko )

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical...

An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )

More from ecancer